The Death Cross Is Now in Place: Our 5% Dividend Stock Safety Net Portfolio Rules
These five safety net portfolio stocks pay a 5% or higher dividend and have consistently raised their payouts over many decades.
These five safety net portfolio stocks pay a 5% or higher dividend and have consistently raised their payouts over many decades.
Four healthcare dividend stocks with significant upside potential and safe dividends look like outstanding ideas for investors worn out from tariff-related volatility.
Good news: these four high-quality dividend giants are currently available at attractive prices and offering excellent entry points.
Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.
As hedge funds dump tech stocks, these four high-yield dividend stocks make sense for investors regardless of age or investment strategy.
Investors looking for hefty dividend payouts and a relative sense of safety have a wide menu of choices nowadays. Among the standouts in the world of exchange traded funds (ETFs) are the…
The stock market has been a wild roller coaster ride for the past five years, shifting from bull market to bear and back numerous times. It was a good lesson that stocks…
These four high-yield blue chip stocks have dependable and growing dividends that provide reliable streams of passive income.
Growth and income investors who stayed with some of Wall Street's favorite high-yield dividend stocks have had reason to cheer lately.
These high-yield dividend stocks are outstanding ideas for growth and income investors now, as they hold up better during recessions.
Johnson & Johnson has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and reliable stock.
Four top companies all pay at least a 4% dividend are on sale and make sense for investors who may be worried about increased volatility in the stock market.
AbbVie just rewarded its shareholders again with a dividend. This stock has boosted its payout annually for more than 50 years.
Live Updates Deep Dive into ABBV's Earnings Call 11:53am ETRich DupreyLooking through AbbVie’s earnings call, these growth prospects stood out: 1. Skyrizi & Rinvoq Set to Dominate Immunology Market 2025 revenue projection:…
Dependable recurring dividends from quality, high-yield stocks like these five are a recipe for passive income success.